Cationic end-capped siloxane prepolymer for reduced cross-link density
View Patent ↗The present invention relates to hydrophilic dicationic siloxane prepolymers with one polymerizable vinyl moiety instead of two polymerizable vinyl moieties, resulting in contact lenses and/or biomedical devices with reduced cross-link density and modulus without detracting from other properties.
1. A monomer of formula (I)
wherein L 1 , L 2 and L 3 can individually be the same or different and are selected from the group consisting of urethanes, carbonates, carbamates, carboxyl ureidos, sulfonyls, a straight or branched C1-C30 alkyl group, a C1-C30 fluoroalkyl group, a C1-C20 ester group, an alkyl ether, cycloalkyl ether, cycloalkenyl ether, aryl ether, arylalkyl ether, a polyether containing group, an ureido group, an amide group, an amine group, a substituted or unsubstrtuted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkylalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C5-C30 aryl group, a substituted or unsubstituted C5-C30 arylalkyl group, a substituted or unsubstituted C5-C30 heteroaryl group, a substituted or unsubstituted C3-C 30 heterocyclic ring, a substituted or unsubstituted C4-C30 heterocyclolalkyl group, a substituted or unsubstituted C6-C30 heteroarylalkyl group, a C5-C30 fluoroaryl group, or a hydroxyl substituted alkyl ether and combinations thereof; X − is at least a single charged counter ion, n is an integer from 1 to about 300; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, a straight or branched C1-C30 alkyl group, a C1-C30 fluoroalkyl group, a C1-C20 ester group, an alkyl ether, cycloalkyl ether, cycloalkenyl ether, aryl ether, arylalkyl ether, a polyether containing group, an ureido group, an amide group, an amine group, a substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkylalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C5-C30 aryl group, a substituted or unsubstituted C5-C30 arylalkyl group, a substituted or unsubstituted C5-C30 heteroaryl group, a substituted or unsubstituted C3-C30 heterocyclic ring, a substituted or unsubstituted C4-C30 heterocyclolalkyl group, a substituted or unsubstituted C6-C30 heteroarylalkyl group, fluorine, a C5-C30 fluoroaryl group, or a hydroxyl group and V is a free radical polymerizable ethylenically unsaturated organic group.
2. The monomer of claim 1 wherein X − is selected from the group consisting of Cl − , Br − , I − , CF 3 CO 2 − , CH 3 CO 2 − , HCO 3 − , CH 3 SO 4 − , p-toluenesulfonate, HSO 4 − , H 2 PO 4 − , NO 3 − , CH 3 CH(OH)CO 2 − , SO 4 2− , CO 3 2− , HPO 4 2− and mixtures thereof − .
3. The monomer of claim 1 wherein X − is at least a single charged counter ion and is selected from the group consisting of Cl − , Br − , I − , CF 3 CO 2 − , CH 3 CO 2 − , HCO 3 − , CH 3 SO 4 − , p-toluenesulfonate, HSO 4 − , H 2 PO 4 − , NO 3 − , and CH 3 CH(OH)CO 2 − and mixtures thereof.
4. The monomer of claim 1 having a structure selected from the group consisting of
5. A monomer mix useful for making polymerized biomaterials comprising at least one monomer of claim 1 and at least one second monomer.
6. The monomer mix of claim 5 , further comprising in addition to the second monomer a hydrophobic monomer and a hydrophilic monomer.
7. The monomer mix of claim 5 wherein the second monomer is selected from the group consisting of unsaturated carboxylic acids, acrylic substituted alcohols, vinyl lactams, acrylamides, methacrylates, hydrophilic vinyl carbonates, hydrophilic vinyl carbamate monomers, hydrophilic oxazolone monomers, and mixtures thereof.
8. A device comprising the monomer of claim 1 as a polymerized comonomer.
9. The device of claim 8 wherein the device is a contact lens.
10. The device of claim 9 wherein the contact lens is a rigid gas permeable contact lens.
11. The device of claim 9 wherein the contact lens is a soft contact lens.
12. The device of claim 9 wherein the contact lens is a hydrogel contact lens.
13. The device of claim 8 wherein the device is an intraocular lens.
14. The device of claim 13 wherein the intraocular lens is a phakic intraocular lens.
15. The device of claim 13 wherein the intraocular lens is an aphakic intraocular lens.
16. The device of claim 8 wherein the device is a conical implant.
17. The device of claim 8 wherein the device is selected from the group consisting of heart valves, intraocular lenses, films, surgical devices, vessel substitutes, intrauterine devices, membranes, diaphragms, surgical implants, blood vessels, artificial ureters, artificial breast tissue, membranes for kidney dialysis machines, membranes for heart/lung machines, catheters, mouth guards, denture liners, ophthalmic devices, and contact lenses.
18. A method of making a device comprising
providing a monomer mixture comprising the monomer of claim 1 and at least a second monomer;
subjecting the monomer mixture to polymerizing conditions to provide a polymerized device, and
extracting the polymerized device.
19. The method of claim 18 wherein the step of extracting is performed with non-flammable solvents.
20. The method of claim 18 wherein the step of extracting is performed with water.
21. The monomer mix of claim 5 wherein the second monomer is selected from the group consisting of methacrylic acid, acrylic acid, 2-hydroxyethylmethacrylate, 2-hydroxyethylacrylate, N-vinyl pyrrolidone (NVP), N-vinyl caprolactone, methacrylamide, N,N-dimethylacrylamide, ethylene glycol dimethacrylate, methyl methacrylate, allyl methacrylate, 3-methacryloyloxypropyl tris(trimethylsiloxy)silane and mixtures thereof.
22. The method of claim 18 , further comprising the step of packaging and sterilizing the polymerized device.